Understanding bacterial resistance to antimicrobial peptides: From the surface to deep inside

Biochimica et Biophysica Acta - Biomembranes

Volumn 1848, Issue 11, 2015, Pages 3078-3088

  Maria Neto, Simone ^a   De Almeida, Keyla Caroline ^b   Macedo, Maria Ligia Rodrigues ^a   Franco, Octávio Luiz ^b,c  

^a FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

^b UNIVERSIDADE CATÓLICA DE BRASÍLIA   (Brazil)

^c UNIVERSIDADE CATÓLICA DOM BOSCO   (Brazil)

Author keywords

Antimicrobial peptides; Bacterial membranes; Bacterial resistance; Cell walls; Mass spectrometry

Indexed keywords

AMINOGLYCOSIDE; CAPREOMYCIN; COLICIN; COLICIN E2; COLICIN M; LIPID A; POLYPEPTIDE ANTIBIOTIC AGENT; POLYSACCHARIDE; QUINOLONE DERIVATIVE; RESISTOME; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE;

ANTIBIOTIC RESISTANCE; BACTERIAL CELL WALL; BACTERIAL INFECTION; BACTERIAL MEMBRANE; BACTERIAL STRAIN; CELL METABOLISM; DISEASE CONTROL; HUMAN; MICROBIAL METABOLISM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; REVIEW; ANIMAL; BACTERIAL INFECTIONS; BACTERIUM; CELL MEMBRANE; CELL WALL; DRUG EFFECTS; HIGH THROUGHPUT SCREENING; HOST PATHOGEN INTERACTION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; MICROBIOLOGY; PATHOGENICITY; PROCEDURES; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; BACTERIAL INFECTIONS; CELL MEMBRANE; CELL WALL; DRUG RESISTANCE, BACTERIAL; HIGH-THROUGHPUT SCREENING ASSAYS; HOST-PATHOGEN INTERACTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; SIGNAL TRANSDUCTION;

EID: 84943665177     PISSN: 00052736     EISSN: 18792642     Source Type: Journal    
DOI: 10.1016/j.bbamem.2015.02.017     Document Type: Review

References (155)

1. H. Grundmann, K.P. Klugman, T. Walsh, P. Ramon-Pardo, B. Sigauque, W. Khan, R. Laxminarayan, A. Heddini, and J. Stelling A framework for global surveillance of antibiotic resistance Drug Resist. Updat. 14 2011 79 87
2. M. Morar, and G.D. Wright The genomic enzymology of antibiotic resistance Annu. Rev. Genet. 44 2010 25 51
3. CDC Antibiotic resistance threats in the United States United States Department of Health and Human Services Centers for Disease Control and Prevention 2013 (http://www.cdc.gov/drugresistance/threat-report-2013/)
4. K.L. Brown, and R.E. Hancock Cationic host defense (antimicrobial) peptides Curr. Opin. Immunol. 18 2006 24 30
5. A. Ghosh, R.K. Kar, J. Jana, A. Saha, B. Jana, J. Krishnamoorthy, D. Kumar, S. Ghosh, S. Chatterjee, and A. Bhunia Indolicidin targets duplex DNA: structural and mechanistic insight through a combination of spectroscopy and microscopy ChemMedChem 9 2014 2052 2058
6. G. Hao, Y.H. Shi, Y.L. Tang, and G.W. Le The intracellular mechanism of action on Escherichia coli of BF2-A/C, two analogues of the antimicrobial peptide Buforin 2 J. Microbiol. 51 2013 200 206
7. A. Dangel, N. Ackermann, O. Abdel-Hadi, R. Maier, K. Onder, P. Francois, C.W. Muller, J. Pane-Farre, S. Engelmann, J. Schrenzel, J. Heesemann, and C. Lindermayr A de novo-designed antimicrobial peptide with activity against multiresistant Staphylococcus aureus acting on RsbW kinase FASEB J. 27 2013 4476 4488
8. L.T. Nguyen, E.F. Haney, and H.J. Vogel The expanding scope of antimicrobial peptide structures and their modes of action Trends Biotechnol. 29 2011 464 472
9. E. Forde, and M. Devocelle Pro-moieties of antimicrobial peptide prodrugs Molecules 20 2015 1210 1227
10. S. Maria-Neto, E.S. Cândido, D.R. Rodrigues, D.A. de Sousa, E.M. da Silva, L.M. de Moraes, A.J. Otero-Gonzalez, B.S. Magalhães, S.C. Dias, and O.L. Franco Deciphering the magainin resistance process of Escherichia coli strains in light of the cytosolic proteome Antimicrob. Agents Chemother. 56 2012 1714 1724
11. N.S. Parachin, and O.L. Franco New edge of antibiotic development: antimicrobial peptides and corresponding resistance Front. Microbiol. 5 2014 147
12. A. Rodriguez-Rojas, O. Makarova, and J. Rolff Antimicrobials, stress and mutagenesis PLoS Pathog. 10 2014 e1004445
13. T.B. Lima, M.F. Pinto, S.M. Ribeiro, L.A. de Lima, J.C. Viana, N. Gomes Júnior, E.E.S. Cândido, S.C. Dias, and O.L. Franco Bacterial resistance mechanism: what proteomics can elucidate FASEB J. 27 2013 1291 1303
14. J.H. Jung, E.J. Yoon, E.C. Choi, and S.S. Choi Development of TaqMan probe-based real-time PCR method for erm(A), erm(B), and erm(C), rapid detection of macrolide-lincosamide-streptogramin B resistance genes, from clinical isolates J. Microbiol. Biotechnol. 19 2009 1464 1469
15. S.J. Cavalieri, R.J. Harbeck, Y.S. McCarter, J.H. Ortez, I.D. Rankin, R.L. Sautter, S.E. Sharp, and C.A. Spiegel Manual of antimicrobial susceptibility testing vol. 9 2005 236
16. CLSI Performance standards for antimicrobial susceptibility testing; 24th informational supplement P.A. Wayne, CLSI document M100-S24 2014 144
17. T. Winstanley, and P. Courvalin Expert systems in clinical microbiology Clin. Microbiol. Rev. 24 2011 515 556
18. E. Stürenburg, I. Sobottka, H.H. Feucht, D. Mack, and R. Laufs Comparison of BDPhoenix and VITEK2 automated antimicrobial susceptibility test systems for extended-spectrum beta-lactamase detection in Escherichia coli and Klebsiella species clinical isolates Diagn. Microbiol. Infect. Dis. 45 2003 29 34
19. I. Otto-Karg, S. Jandl, T. Müller, B. Stirzel, M. Frosch, H. Hebestreit, and M. Abele-Horn Validation of Vitek 2 nonfermenting Gram-negative cards and Vitek 2 version 4.02 software for identification and antimicrobial susceptibility testing of nonfermenting Gram-negative rods from patients with cystic fibrosis J. Clin. Microbiol. 47 2009 3283 3288
20. J.R. Lo-Ten-Foe, A.M. de Smet, B.M. Diederen, J.A. Kluytmans, and P.H. van Keulen Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains Antimicrob. Agents Chemother. 51 2007 3726 3730
21. A. Voss, J.W. Mouton, E.P. van Elzakker, R.G. Hendrix, W. Goessens, J.A. Kluytmans, P.F. Krabbe, H.J. de Neeling, J.H. Sloos, N. Oztoprak, R.A. Howe, and T.R. Walsh A multi-center blinded study on the efficiency of phenotypic screening methods to detect glycopeptide intermediately susceptible Staphylococcus aureus (GISA) and heterogeneous GISA (h-GISA) Ann. Clin. Microbiol. Antimicrob. 6 2007 9
22. L. Bernard, P. Vaudaux, P. Rohner, E. Huggler, M. Armanet, D. Pittet, D.P. Lew, and J. Schrenzel Comparative analysis and validation of different assays for glycopeptide susceptibility among methicillin-resistant Staphylococcus aureus strains J. Microbiol. Methods 57 2004 231 239
23. M. Muroi, K. Shima, M. Igarashi, Y. Nakagawa, and K. Tanamoto Application of matrix-assisted laser desorption ionization-time of flight mass spectrometry for discrimination of laboratory-derived antibiotic-resistant bacteria Biol. Pharm. Bull. 35 2012 1841 1845
24. G. Werner, A. Serr, S. Schutt, C. Schneider, I. Klare, W. Witte, and C. Wendt Comparison of direct cultivation on a selective solid medium, polymerase chain reaction from an enrichment broth, and the BD GeneOhm VanR Assay for identification of vancomycin-resistant enterococci in screening specimens Diagn. Microbiol. Infect. Dis. 70 2011 512 521
25. K.L. Blake, and A.J. O'Neill Transposon library screening for identification of genetic loci participating in intrinsic susceptibility and acquired resistance to antistaphylococcal agents J. Antimicrob. Chemother. 68 2013 12 16
26. D.T. Nguyen, E. Yeh, S. Perry, R.F. Luo, B.A. Pinsky, B.P. Lee, D. Sisodiya, E.J. Baron, and N. Banaei Real-time PCR testing for mecA reduces vancomycin usage and length of hospitalization for patients infected with methicillin-sensitive staphylococci J. Clin. Microbiol. 48 2010 785 790
27. N. Motamedi, L. Danelishvili, and L.E. Bermudez Identification of Mycobacterium avium genes associated with resistance to host antimicrobial peptides J. Med. Microbiol. 63 2014 923 930
28. C. Surcouf, S. Heng, C. Pierre-Audigier, V. Cadet-Daniel, A. Namouchi, A. Murray, B. Gicquel, and B. Guillard Molecular detection of fluoroquinolone-resistance in multi-drug resistant tuberculosis in Cambodia suggests low association with XDR phenotypes BMC Infect. Dis. 11 2011 255
29. D.V. Zimenkov, O.V. Antonova, A.V. Kuz'min, Y.D. Isaeva, L.Y. Krylova, S.A. Popov, A.S. Zasedatelev, V.M. Mikhailovich, and D.A. Gryadunov Detection of second-line drug resistance in Mycobacterium tuberculosis using oligonucleotide microarrays BMC Infect. Dis. 13 2013 240
30. E.C. Spindler, N.R. Boyle, R.E. Hancock, and R.T. Gill Genome-wide identification of genes conferring energy related resistance to a synthetic antimicrobial peptide (Bac8c) PLoS ONE 8 2013 e55052
31. J. Chen, Z. Yu, F.C. Michel, T. Wittum, and M. Morrison Development and application of real-time PCR assays for quantification of erm genes conferring resistance to macrolides-lincosamides-streptogramin B in livestock manure and manure management systems Appl. Environ. Microbiol. 73 2007 4407 4416
32. F. Valencia-Shelton, and M. Loeffelholz Nonculture techniques for the detection of bacteremia and fungemia Future Microbiol 9 2014 543 559
33. A. Cossu, L.A. Sechi, E. Bandino, S. Zanetti, and V. Rosu Expression profiling of Mycobacterium tuberculosis H37Rv and Mycobacterium smegmatis in acid-nitrosative multi-stress displays defined regulatory networks Microb. Pathog. 65 2013 89 96
34. J. Agarwal, S. Srivastava, and M. Singh Pathogenomics of uropathogenic Escherichia coli Indian J. Med. Microbiol. 30 2012 141 149
35. P. Jorth, U. Trivedi, K. Rumbaugh, and M. Whiteley Probing bacterial metabolism during infection using high-resolution transcriptomics J. Bacteriol. 195 2013 4991 4998
36. M.E. Taveirne, C.M. Theriot, J. Livny, and V.J. DiRita The complete Campylobacter jejuni transcriptome during colonization of a natural host determined by RNAseq PLoS ONE 8 2013 e73586
37. J. Osmundson, S. Dewell, and S.A. Darst RNA-Seq reveals differential gene expression in Staphylococcus aureus with single-nucleotide resolution PLoS ONE 8 2013 e76572
38. S. Kamenšek, and D. Žgur-Bertok Global transcriptional responses to the bacteriocin colicin M in Escherichia coli BMC Microbiol. 13 2013 42
39. Y. Taniguchi, P.J. Choi, G.W. Li, H. Chen, M. Babu, J. Hearn, A. Emili, and X.S. Xie Quantifying E. coli proteome and transcriptome with single-molecule sensitivity in single cells Science 329 2010 533 538
40. S. Berthoumieux, M. Brilli, D. Kahn, H. de Jong, and E. Cinquemani On the identifiability of metabolic network models J. Math. Biol. 67 2013 1795 1832
41. B.W. Ying, S. Seno, F. Kaneko, H. Matsuda, and T. Yomo Multilevel comparative analysis of the contributions of genome reduction and heat shock to the Escherichia coli transcriptome BMC Genomics 14 2013 25
42. S.H. Yoon, M.J. Han, S.Y. Lee, K.J. Jeong, and J.S. Yoo Combined transcriptome and proteome analysis of Escherichia coli during high cell density culture Biotechnol. Bioeng. 81 2003 753 767
43. S.J. Fey, and P.M. Larsen 2D or not 2D. Two-dimensional gel electrophoresis Curr. Opin. Chem. Biol. 5 2001 26 33
44. P. Mallick, and B. Kuster Proteomics: a pragmatic perspective Nat. Biotechnol. 28 2010 695 709
45. A. Rogowska-Wrzesinska, M.C. Le Bihan, M. Thaysen-Andersen, and P. Roepstorff 2D gels still have a niche in proteomics J. Proteome 88 2013 4 13
46. H. Chen, Y. Liu, C. Zhao, D. Xiao, J. Zhang, F. Zhang, M. Chen, and H. Wang Comparative proteomics-based identification of genes associated with glycopeptide resistance in clinically derived heterogeneous vancomycin-intermediate Staphylococcus aureus strains PLoS ONE 8 2013 e66880
47. E. Madhava Charyulu, A. Gnanamani, and A.B. Mandal Identification and discrimination of methicillin resistant Staphylococcus aureus strains isolated from burn wound sites using PCR and authentication with MALDI-TOF-MS Indian J. Microbiol. 52 2012 337 345
48. M.V. Malakhova, V.A. Vereshchagin, E.N. Il'ina, V.M. Govorun, O.I.U. Filimonova, S.A. Grudinina, and S.V. Sidorenko MALDI-ToF mass-spectrometry in analysis of genetically determined resistance of Streptococcus pneumoniae to fluoroquinolones Antibiot. Khimioter. 52 2007 10 17
49. J.E. Camara, and F.A. Hays Discrimination between wild-type and ampicillin-resistant Escherichia coli by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry Anal. Bioanal. Chem. 389 2007 1633 1638
50. K.C. de Almeida, T.B. Lima, D.O. Motta, O.N. Silva, B.S. Magalhaes, S.C. Dias, and O.L. Franco Investigating specific bacterial resistance to AMPs by using a magainin I-resistant Escherichia coli model J. Antibiot. (Tokyo) 67 2014 681 687
51. K.E. Tan, B.C. Ellis, R. Lee, P.D. Stamper, S.X. Zhang, and K.C. Carroll Prospective evaluation of a matrix-assisted laser desorption ionization-time of flight mass spectrometry system in a hospital clinical microbiology laboratory for identification of bacteria and yeasts: a bench-by-bench study for assessing the impact on time to identification and cost-effectiveness J. Clin. Microbiol. 50 2012 3301 3308
52. V.D. Rosenthal Health-care-associated infections in developing countries Lancet 377 2011 186 188
53. X. Peng, C. Xu, H. Ren, X. Lin, L. Wu, and S. Wang Proteomic analysis of the sarcosine-insoluble outer membrane fraction of Pseudomonas aeruginosa responding to ampicillin, kanamycin, and tetracycline resistance J. Proteome Res. 4 2005 2257 2265
54. H. Nikaido Molecular basis of bacterial outer membrane permeability revisited Microbiol. Mol. Biol. Rev. 67 2003 593 656
55. C.J. Shen, T.Y. Kuo, C.C. Lin, L.P. Chow, and W.J. Chen Proteomic identification of membrane proteins regulating antimicrobial peptide resistance in Vibrio parahaemolyticus J. Appl. Microbiol. 108 2010 1398 1407
56. R. Pieper, C.L. Gatlin-Bunai, E.F. Mongodin, P.P. Parmar, S.T. Huang, D.J. Clark, R.D. Fleischmann, S.R. Gill, and S.N. Peterson Comparative proteomic analysis of Staphylococcus aureus strains with differences in resistance to the cell wall-targeting antibiotic vancomycin Proteomics 6 2006 4246 4258
57. W.C. Wimley Describing the mechanism of antimicrobial peptide action with the interfacial activity model ACS Chem. Biol. 5 2010 905 917
58. F. Guilhelmelli, N. Vilela, P. Albuquerque, S. Derengowski Lda, I. Silva-Pereira, and C.M. Kyaw Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistance Front. Microbiol. 4 2013 353
59. M. Zucca, S. Scutera, and D. Savoia New antimicrobial frontiers Mini Rev. Med. Chem. 11 2011 888 900
60. Y. Huang, J. Huang, and Y. Chen Alpha-helical cationic antimicrobial peptides: relationships of structure and function Protein Cell 1 2010 143 152
61. M. Otto Bacterial sensing of antimicrobial peptides Contrib. Microbiol. 16 2009 136 149
62. M. Li, D.J. Cha, Y. Lai, A.E. Villaruz, D.E. Sturdevant, and M. Otto The antimicrobial peptide-sensing system aps of Staphylococcus aureus Mol. Microbiol. 66 2007 1136 1147
63. O. Rolin, S.J. Muse, C. Safi, S. Elahi, V. Gerdts, L.E. Hittle, R.K. Ernst, E.T. Harvill, and A. Preston Enzymatic modification of lipid A by ArnT protects Bordetella bronchiseptica against cationic peptides and is required for transmission Infect. Immun. 82 2014 491 499
64. A. Skiada, A. Markogiannakis, D. Plachouras, and G.L. Daikos Adaptive resistance to cationic compounds in Pseudomonas aeruginosa Int. J. Antimicrob. Agents 37 2011 187 193
65. A. Beceiro, E. Llobet, J. Aranda, J.A. Bengoechea, M. Doumith, M. Hornsey, H. Dhanji, H. Chart, G. Bou, D.M. Livermore, and N. Woodford Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system Antimicrob. Agents Chemother. 55 2011 3370 3379
66. N.N. Mishra, and A.S. Bayer Correlation of cell membrane lipid profiles with daptomycin resistance in methicillin-resistant Staphylococcus aureus Antimicrob. Agents Chemother. 57 2013 1082 1085
67. W. Dowhan A retrospective: use of Escherichia coli as a vehicle to study phospholipid synthesis and function Biochim. Biophys. Acta 1831 2013 471 494
68. T. Zhang, J.K. Muraih, N. Tishbi, J. Herskowitz, R.L. Victor, J. Silverman, S. Uwumarenogie, S.D. Taylor, M. Palmer, and E. Mintzer Cardiolipin prevents membrane translocation and permeabilization by daptomycin J. Biol. Chem. 289 2014 11584 11591
69. C.M. Ernst, and A. Peschel Broad-spectrum antimicrobial peptide resistance by MprF-mediated aminoacylation and flipping of phospholipids Mol. Microbiol. 80 2011 290 299
70. N.N. Mishra, A.S. Bayer, T.T. Tran, Y. Shamoo, E. Mileykovskaya, W. Dowhan, Z. Guan, and C.A. Arias Daptomycin resistance in enterococci is associated with distinct alterations of cell membrane phospholipid content PLoS ONE 7 2012 e43958
71. A.S. Bayer, N.N. Mishra, G. Sakoulas, P. Nonejuie, C.C. Nast, J. Pogliano, K.T. Chen, S.N. Ellison, M.R. Yeaman, and S.J. Yang Heterogeneity of mprF sequences in methicillin-resistant Staphylococcus aureus clinical isolates: role in cross-resistance between daptomycin and host defense antimicrobial peptides Antimicrob. Agents Chemother. 58 2014 7462 7467
72. E. Cox, A. Michalak, S. Pagentine, P. Seaton, and A. Pokorny Lysylated phospholipids stabilize models of bacterial lipid bilayers and protect against antimicrobial peptides Biochim. Biophys. Acta 1838 2014 2198 2204
73. L. Fernández, W.J. Gooderham, M. Bains, J.B. McPhee, I. Wiegand, and R.E. Hancock Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS Antimicrob. Agents Chemother. 54 2010 3372 3382
74. R. Ohki, K. Giyanto, W. Tateno, S. Masuyama, K. Moriya, and N. Kobayashi Ogasawara, The BceRS two-component regulatory system induces expression of the bacitracin transporter, BceAB, in Bacillus subtilis Mol. Microbiol. 49 2003 1135 1144
75. A. Hiron, M. Falord, J. Valle, M. Débarbouillé, and T. Msadek Bacitracin and nisin resistance in Staphylococcus aureus: a novel pathway involving the BraS/BraR two-component system (SA2417/SA2418) and both the BraD/BraE and VraD/VraE ABC transporters Mol. Microbiol. 81 2011 602 622
76. M. Falord, G. Karimova, A. Hiron, and T. Msadek GraXSR proteins interact with the VraFG ABC transporter to form a five-component system required for cationic antimicrobial peptide sensing and resistance in Staphylococcus aureus Antimicrob. Agents Chemother. 56 2012 1047 1058
77. C.J. Slavetinsky, A. Peschel, and C.M. Ernst Alanyl-phosphatidylglycerol and lysyl-phosphatidylglycerol are translocated by the same MprF flippases and have similar capacities to protect against the antibiotic daptomycin in Staphylococcus aureus Antimicrob. Agents Chemother. 56 2012 3492 3497
78. S. Dintner, R. Heermann, C. Fang, K. Jung, and S. Gebhard A sensory complex consisting of an ATP-binding cassette transporter and a two-component regulatory system controls bacitracin resistance in Bacillus subtilis J. Biol. Chem. 289 2014 27899 27910
79. J. Fernandez-Recio, F. Walas, L. Federici, J. Venkatesh Pratap, V.N. Bavro, R.N. Miguel, K. Mizuguchi, and B. Luisi A model of a transmembrane drug-efflux pump from Gram-negative bacteria FEBS Lett. 578 2004 5 9
80. F.V. Biot, M.M. Lopez, T. Poyot, F. Neulat-Ripoll, S. Lignon, A. Caclard, F.M. Thibault, A. Peinnequin, J.M. Pagès, and E. Valade Interplay between three RND efflux pumps in doxycycline-selected strains of Burkholderia thailandensis PLoS ONE 8 2013 e84068
81. T.K. Janganan, V.N. Bavro, L. Zhang, M.I. Borges-Walmsley, and A.R. Walmsley Tripartite efflux pumps: energy is required for dissociation, but not assembly or opening of the outer membrane channel of the pump Mol. Microbiol. 88 2013 590 602
82. S.C. Parija Textbook of Microbiology & Immunology Second ed. 2014 Elsevier Health Sciences APAC Manesar, India
83. W. Weidel, and H. Pelzer Bagshaped macromolecules - a new outlook on bacterial cell walls Adv. Enzymol. Relat. Areas Mol. Biol. 26 1964 193 232
84. T. Paustian Through the Microscope: Adventures in Microbiology http://www.microbiologytext.com 2012 (Access date: 29/09/2014)
85. L. Dienes, and H.J. Weinberger The L forms of bacteria Bacteriol. Rev. 15 1951 245 288
86. J. Errington L-Form bacteria, cell walls and the origins of life Open Biol. 3 2013 120143
87. T. Ebenhan, O. Gheysens, H.G. Kruger, J.R. Zeevaart, and M.M. Sathekge Antimicrobial peptides: their role as infection-selective tracers for molecular imaging Biomed. Res. Int. 2014 2014 867381
88. J.J. Lopez Cascales, A. Garro, R.D. Porasso, and R.D. Enriz The dynamic action mechanism of small cationic antimicrobial peptides Phys. Chem. Chem. Phys. 16 2014 21694 21705
89. J.C. Henderson, C.D. Fage, J.R. Cannon, J.S. Brodbelt, A.T. Keatinge-Clay, and M.S. Trent Antimicrobial peptide resistance of Vibrio cholerae results from an LPS modification pathway related to nonribosomal peptide synthetases ACS Chem. Biol. 9 2014 2382 2392
90. H. Brade Endotoxin in Health and Disease First ed. 1999 CRC Press United States of America
91. L.E.T. Metzger, J.K. Lee, J.S. Finer-Moore, C.R. Raetz, and R.M. Stroud LpxI structures reveal how a lipid A precursor is synthesized Nat. Struct. Mol. Biol. 19 2012 1132 1138
92. G. Seltmann, and O. Holst The Bacterial Cell Wall 2002 Springer Berlin Heidelberg
93. F.C. Neuhaus, and J. Baddiley A continuum of anionic charge: structures and functions of d-alanyl-teichoic acids in Gram-positive bacteria Microbiol. Mol. Biol. Rev. 67 2003 686 723
94. K.H. Schleifer, and O. Kandler Peptidoglycan types of bacterial cell walls and their taxonomic implications Bacteriol. Rev. 36 1972 407 477
95. D.J. Scheffers, and M.G. Pinho Bacterial cell wall synthesis: new insights from localization studies Microbiol. Mol. Biol. Rev. 69 2005 585 607
96. S.A. Kristian, V. Datta, C. Weidenmaier, R. Kansal, I. Fedtke, A. Peschel, R.L. Gallo, and V. Nizet d-Alanylation of teichoic acids promotes group a streptococcus antimicrobial peptide resistance, neutrophil survival, and epithelial cell invasion J. Bacteriol. 187 2005 6719 6725
97. C.Y. Okumura, and V. Nizet Subterfuge and sabotage: evasion of host innate defenses by invasive Gram-positive bacterial pathogens Annu. Rev. Microbiol. 68 2014 439 458
98. A. Peschel, M. Otto, R.W. Jack, H. Kalbacher, G. Jung, and F. Gotz Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides J. Biol. Chem. 274 1999 8405 8410
99. D.A. Devine, and R.E. Hancock Cationic peptides: distribution and mechanisms of resistance Curr. Pharm. Des. 8 2002 703 714
100. A. Peschel, and L.V. Collins Staphylococcal resistance to antimicrobial peptides of mammalian and bacterial origin Peptides 22 2001 1651 1659
101. A. Peschel, C. Vuong, M. Otto, and F. Gotz The d-alanine residues of Staphylococcus aureus teichoic acids alter the susceptibility to vancomycin and the activity of autolytic enzymes Antimicrob. Agents Chemother. 44 2000 2845 2847
102. K.G. Chan, M. Mayer, E.M. Davis, S.A. Halperin, T.J. Lin, and S.F. Lee Role of d-alanylation of Streptococcus gordonii lipoteichoic acid in innate and adaptive immunity Infect. Immun. 75 2007 3033 3042
103. R. Saar-Dover, A. Bitler, R. Nezer, L. Shmuel-Galia, A. Firon, E. Shimoni, P. Trieu-Cuot, and Y. Shai d-Alanylation of lipoteichoic acids confers resistance to cationic peptides in group B streptococcus by increasing the cell wall density PLoS Pathog. 8 2012 e1002891
104. S.M. McBride, and A.L. Sonenshein The dlt operon confers resistance to cationic antimicrobial peptides in Clostridium difficile Microbiology 157 2011 1457 1465
105. E.T. Rietschel, T. Kirikae, F.U. Schade, U. Mamat, G. Schmidt, H. Loppnow, A.J. Ulmer, U. Zahringer, U. Seydel, F. Di Padova, and et al. Bacterial endotoxin: molecular relationships of structure to activity and function FASEB J. 8 1994 217 225
106. C.R. Raetz, and C. Whitfield Lipopolysaccharide endotoxins Annu. Rev. Biochem. 71 2002 635 700
107. J.S. Gunn, K.B. Lim, J. Krueger, K. Kim, L. Guo, M. Hackett, and S.I. Miller PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance Mol. Microbiol. 27 1998 1171 1182
108. J.S. Gunn, S.S. Ryan, J.C. Van Velkinburgh, R.K. Ernst, and S.I. Miller Genetic and functional analysis of a PmrA-PmrB-regulated locus necessary for lipopolysaccharide modification, antimicrobial peptide resistance, and oral virulence of Salmonella enterica serovar typhimurium Infect. Immun. 68 2000 6139 6146
109. R.E. Bishop, H.S. Gibbons, T. Guina, M.S. Trent, S.I. Miller, and C.R. Raetz Transfer of palmitate from phospholipids to lipid A in outer membranes of Gram-negative bacteria EMBO J. 19 2000 5071 5080
110. M.M. Wosten, L.F. Kox, S. Chamnongpol, F.C. Soncini, and E.A. Groisman A signal transduction system that responds to extracellular iron Cell 103 2000 113 125
111. L. Johnson, S.R. Horsman, L. Charron-Mazenod, A.L. Turnbull, H. Mulcahy, M.G. Surette, and S. Lewenza Extracellular DNA-induced antimicrobial peptide resistance in Salmonella enterica serovar Typhimurium BMC Microbiol. 13 2013 115
112. J.J. Bijlsma, and E.A. Groisman Making informed decisions: regulatory interactions between two-component systems Trends Microbiol. 11 2003 359 366
113. J.S. Gunn The Salmonella PmrAB regulon: lipopolysaccharide modifications, antimicrobial peptide resistance and more Trends Microbiol. 16 2008 284 290
114. S.R. Murray, R.K. Ernst, D. Bermudes, S.I. Miller, and K.B. Low pmrA(Con) confers pmrHFIJKL-dependent EGTA and polymyxin resistance on msbB Salmonella by decorating lipid A with phosphoethanolamine J. Bacteriol. 189 2007 5161 5169
115. W.W. Navarre, T.A. Halsey, D. Walthers, J. Frye, M. McClelland, J.L. Potter, L.J. Kenney, J.S. Gunn, F.C. Fang, and S.J. Libby Co-regulation of Salmonella enterica genes required for virulence and resistance to antimicrobial peptides by SlyA and PhoP/PhoQ Mol. Microbiol. 56 2005 492 508
116. L.R. Prost, and S.I. Miller The Salmonellae PhoQ sensor: mechanisms of detection of phagosome signals Cell. Microbiol. 10 2008 576 582
117. 2 +-induced gene regulation in Pseudomonas aeruginosa J. Bacteriol. 188 2006 3995 4006
118. K. Kawasaki, K. China, and M. Nishijima Release of the lipopolysaccharide deacylase PagL from latency compensates for a lack of lipopolysaccharide aminoarabinose modification-dependent resistance to the antimicrobial peptide polymyxin B in Salmonella enterica J. Bacteriol. 189 2007 4911 4919
119. M. Reines, E. Llobet, C.M. Llompart, D. Moranta, C. Perez-Gutierrez, and J.A. Bengoechea Molecular basis of Yersinia enterocolitica temperature-dependent resistance to antimicrobial peptides J. Bacteriol. 194 2012 3173 3188
120. J.V. Hankins, J.A. Madsen, D.K. Giles, J.S. Brodbelt, and M.S. Trent Amino acid addition to Vibrio cholerae LPS establishes a link between surface remodeling in Gram-positive and Gram-negative bacteria Proc. Natl. Acad. Sci. U. S. A. 109 2012 8722 8727
121. Y.L. Tzeng, K.D. Ambrose, S. Zughaier, X. Zhou, Y.K. Miller, W.M. Shafer, and D.S. Stephens Cationic antimicrobial peptide resistance in Neisseria meningitidis J. Bacteriol. 187 2005 5387 5396
122. T. Nishino An electron microscopic study of antagonism between cephalexin and erythromycin in Staphylococcus aureus Jpn. J. Microbiol. 19 1975 53 63
123. L. Cui, X. Ma, K. Sato, K. Okuma, F.C. Tenover, E.M. Mamizuka, C.G. Gemmell, M.N. Kim, M.C. Ploy, N. El-Solh, V. Ferraz, and K. Hiramatsu Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus J. Clin. Microbiol. 41 2003 5 14
124. L. Cui, H. Murakami, K. Kuwahara-Arai, H. Hanaki, and K. Hiramatsu Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50 Antimicrob. Agents Chemother. 44 2000 2276 2285
125. M. Kawai, S. Yamada, A. Ishidoshiro, Y. Oyamada, H. Ito, and J. Yamagishi Cell-wall thickness: possible mechanism of acriflavine resistance in meticillin-resistant Staphylococcus aureus J. Med. Microbiol. 58 2009 331 336
126. N.Y. Yount, and M.R. Yeaman Peptide antimicrobials: cell wall as a bacterial target Ann. N. Y. Acad. Sci. 1277 2013 127 138
127. L. Cui, E. Tominaga, H.M. Neoh, and K. Hiramatsu Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus Antimicrob. Agents Chemother. 50 2006 1079 1082
128. S.J. Yang, C.C. Nast, N.N. Mishra, M.R. Yeaman, P.D. Fey, and A.S. Bayer Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanisms Antimicrob. Agents Chemother. 54 2010 3079 3085
129. N.E. Kramer, E.J. Smid, J. Kok, B. de Kruijff, O.P. Kuipers, and E. Breukink Resistance of Gram-positive bacteria to nisin is not determined by lipid II levels FEMS Microbiol. Lett. 239 2004 157 161
130. N.K. Taneja, T. Ganguly, L.O. Bakaletz, K.J. Nelson, P. Dubey, L.B. Poole, and R. Deora d-Alanine modification of a protease-susceptible outer membrane component by the Bordetella pertussis dra locus promotes resistance to antimicrobial peptides and polymorphonuclear leukocyte-mediated killing J. Bacteriol. 195 2013 5102 5111
131. L.J. Beamer, S.F. Carroll, and D. Eisenberg Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution Science 276 1997 1861 1864
132. M.R. Yeaman, and N.Y. Yount Mechanisms of antimicrobial peptide action and resistance Pharmacol. Rev. 55 2003 27 55
133. A. Schmidtchen, I.M. Frick, E. Andersson, H. Tapper, and L. Bjorck Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37 Mol. Microbiol. 46 2002 157 168
134. M. Sieprawska-Lupa, P. Mydel, K. Krawczyk, K. Wojcik, M. Puklo, B. Lupa, P. Suder, J. Silberring, M. Reed, J. Pohl, W. Shafer, F. McAleese, T. Foster, J. Travis, and J. Potempa Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases Antimicrob. Agents Chemother. 48 2004 4673 4679
135. M. Jusko, J. Potempa, A.Y. Karim, M. Ksiazek, K. Riesbeck, P. Garred, S. Eick, and A.M. Blom A metalloproteinase karilysin present in the majority of Tannerella forsythia isolates inhibits all pathways of the complement system J. Immunol. 188 2012 2338 2349
136. J. Koziel, A.Y. Karim, K. Przybyszewska, M. Ksiazek, M. Rapala-Kozik, K.A. Nguyen, and J. Potempa Proteolytic inactivation of LL-37 by karilysin, a novel virulence mechanism of Tannerella forsythia J. Innate Immun. 2 2010 288 293
137. R. Belas, J. Manos, and R. Suvanasuthi Proteus mirabilis ZapA metalloprotease degrades a broad spectrum of substrates, including antimicrobial peptides Infect. Immun. 72 2004 5159 5167
138. Z. Sun, J. Zhong, X. Liang, J. Liu, X. Chen, and L. Huan Novel mechanism for nisin resistance via proteolytic degradation of nisin by the nisin resistance protein NSR Antimicrob. Agents Chemother. 53 2009 1964 1973
139. X. Liang, Z. Sun, J. Zhong, Q. Zhang, and L. Huan Adverse effect of nisin resistance protein on nisin-induced expression system in Lactococcus lactis Microbiol. Res. 165 2010 458 465
140. M. Mattiuzzo, C. De Gobba, G. Runti, M. Mardirossian, A. Bandiera, R. Gennaro, and M. Scocchi Proteolytic activity of Escherichia coli oligopeptidase B against proline-rich antimicrobial peptides J. Microbiol. Biotechnol. 24 2014 160 167
141. P. Nyberg, M. Rasmussen, and L. Bjorck Alpha2-macroglobulin-proteinase complexes protect Streptococcus pyogenes from killing by the antimicrobial peptide LL-37 J. Biol. Chem. 279 2004 52820 52823
142. L. Johansson, P. Thulin, P. Sendi, E. Hertzen, A. Linder, P. Akesson, D.E. Low, B. Agerberth, and A. Norrby-Teglund Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humans Infect. Immun. 76 2008 3399 3404
143. M. Rasmussen, H.-P. Müller, and L. Björck Protein GRAB of Streptococcus pyogenes regulates proteolysis at the bacterial surface by binding α2-macroglobulin J. Biol. Chem. 274 1999 15336 15344
144. A. Schmidtchen, I.M. Frick, and L. Bjorck Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial alpha-defensin Mol. Microbiol. 39 2001 708 713
145. X. Lauth, M. von Kockritz-Blickwede, C.W. McNamara, S. Myskowski, A.S. Zinkernagel, B. Beall, P. Ghosh, R.L. Gallo, and V. Nizet M1 protein allows Group A streptococcal survival in phagocyte extracellular traps through cathelicidin inhibition J. Innate Immun. 1 2009 202 214
146. H.C. Maisey, D. Quach, M.E. Hensler, G.Y. Liu, R.L. Gallo, V. Nizet, and K.S. Doran A group B streptococcal pilus protein promotes phagocyte resistance and systemic virulence FASEB J. 22 2008 1715 1724
147. U. Romling, S. Kjelleberg, S. Normark, L. Nyman, B.E. Uhlin, and B. Akerlund Microbial biofilm formation: a need to act J. Intern. Med. 276 2014 98 110
148. D. Dufour, V. Leung, and C.M. Lévesque Bacterial biofilm: structure, function, and antimicrobial resistance Endod. Top. 22 2010 2 16
149. M. Di Luca, G. Maccari, and R. Nifosi Treatment of microbial biofilms in the post-antibiotic era: prophylactic and therapeutic use of antimicrobial peptides and their design by bioinformatics tools Pathog. Dis. 70 2014 257 270
150. C. de la Fuente-Nunez, V. Korolik, M. Bains, U. Nguyen, E.B. Breidenstein, S. Horsman, S. Lewenza, L. Burrows, and R.E. Hancock Inhibition of bacterial biofilm formation and swarming motility by a small synthetic cationic peptide Antimicrob. Agents Chemother. 56 2012 2696 2704
151. Y. Kai-Larsen, P. Luthje, M. Chromek, V. Peters, X. Wang, A. Holm, L. Kadas, K.O. Hedlund, J. Johansson, M.R. Chapman, S.H. Jacobson, U. Romling, B. Agerberth, and A. Brauner Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37 PLoS Pathog. 6 2010 e1001010
152. H. Mulcahy, L. Charron-Mazenod, and S. Lewenza Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms PLoS Pathog. 4 2008 e1000213
153. E.E. Gill, O.L. Franco, and R.E. Hancock Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens Chem. Biol. Drug Des. 85 2015 56 78
154. O.L. Franco Elucidating novel bacterial targets and designing unusual antimicrobial peptides: two faces of the same proteomic coin J. Proteome Bioinforma. S8 2014 001
155. T.W. Bristow, A.D. Ray, A. O'Kearney-McMullan, L. Lim, B. McCullough, and A. Zammataro On-line monitoring of continuous flow chemical synthesis using a portable, small footprint mass spectrometer J. Am. Soc. Mass Spectrom. 25 2014 1794 1802